Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production.

An amplified NS0 cell line transfected with a vector expressing a humanized monoclonal antibody (MAb) against CD-18 and glutamine synthetase (GS) was cultivated in a 1.5 L fed-batch culture using a serum-free, glutamine-free medium. Concentrated solutions of key nutrient components were fed periodically using a simple feeding control strategy. Feeding amounts were adjusted daily based on the integral of viable cell concentration over time (IVC) and assumed constant specific nutrient consumption rates or yields to maintain concentrations of the key nutrient components around their initial levels. On-line oxygen uptake rate (OUR) measurement was used to aid empirically the adjustment of the feeding time points and amounts by inferring time points of nutrient depletion. Through effective nutritional control, both cell growth phase and culture lifetime were prolonged significantly, resulting in a maximal viable cell concentration of 6.6 x 10(9) cells/L and a final IVC of 1.6 x 10(12) cells-h/L at 672 h. The final MAb concentration reached more than 2.7 g/L. In this fed-batch culture, cellular metabolism shifts were repeatedly observed. Accompanying the culture phase transition from the exponential growth to the stationary phase, lactate, which was produced in the exponential growth phase, became consumed. The time point at which this metabolism shift occurred corresponded to that of rapid decrease of OUR, which most likely was caused by nutrient depletion. This transition coincided with the onset of ammonia, glutamate and glutamine accumulation. With removal of the nutrient depletion by increasing the daily nutrient feeding amount, OUR recovered and viable cell concentration increased, while cell metabolism shifted again. Instead of consumption, lactate became produced again. These results suggest close relationships among nutrient depletion, cell metabolism transition, and cell death. (c) 1997 John Wiley & Sons, Inc. Biotechnol Bioeng 55: 783-792, 1997.

[1]  T. Bibila,et al.  In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production , 1995, Biotechnology progress.

[2]  R. Mutharasan,et al.  Cell cycle‐ and growth phase‐dependent variations in size distribution, antibody productivity, and oxygen demand in hybridoma cultures , 1990, Biotechnology and bioengineering.

[3]  Weichang Zhou,et al.  High viable cell concentration fed‐batch cultures of hybridoma cells through on‐line nutrient feeding , 1995, Biotechnology and bioengineering.

[4]  F Franek,et al.  Starvation-induced programmed death of hybridoma cells: Prevention by amino acid mixtures. , 1995, Biotechnology and bioengineering.

[5]  H. Ueda,et al.  Overexpression of bcl‐2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production , 1995, Biotechnology and bioengineering.

[6]  S S Ozturk,et al.  Real-time monitoring and control of glucose and lactate concentrations in a mammalian cell perfusion reactor. , 1997, Biotechnology and bioengineering.

[7]  B. Buckland,et al.  Monoclonal Antibody Process Development Using Medium Concentrates , 1994, Biotechnology progress.

[8]  D K Robinson,et al.  Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process , 1994, Biotechnology and bioengineering.

[9]  E. Heinzle,et al.  On‐line estimation of viable cells in a hybridoma culture at various DO levels using ATP balancing and redox potential measurement , 2000, Biotechnology and bioengineering.

[10]  D. King,et al.  High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker , 1992, Bio/Technology.

[11]  M. Silberklang,et al.  Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.

[12]  Daniel I. C. Wang,et al.  High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor. , 2000, Biotechnology and bioengineering.

[13]  W M Miller,et al.  Regulation of animal cell metabolism in bioreactors. , 1991, Biotechnology.

[14]  Ashok Mulchandani,et al.  Recent Advances in Bioprocess Monitoring and Control , 1996 .

[15]  A J Sinskey,et al.  Reduction of waste product excretion via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells , 1986, Biotechnology and bioengineering.

[16]  K. Gull,et al.  NSO myeloma cell death: Influence of bcl‐2 overexpression , 1996, Biotechnology and bioengineering.

[17]  S. Mercille,et al.  Induction of apoptosis in nutrient‐deprived cultures of hybridoma and myeloma cells , 1994, Biotechnology and bioengineering.

[18]  Weichang Zhou,et al.  On‐line characterization of a hybridoma cell culture process , 1994, Biotechnology and bioengineering.